# Neuromarketing-Digital Personalization Framework — Evidence Base

## Primary Source

**Mandal, A., & Tabib, P.A.** (2026). "A Conceptual Neuromarketing-Digital Personalization Framework: Linking Neural Biomarkers to Consumer Journey Stages." *Advances in Consumer Research*, 2026.

A PRISMA-guided systematic review of 30 high-quality studies retrieved from Scopus and Web of Science (publication window 2018–2025). The review proposes a conceptual **Neuromarketing-Digital Personalization Framework** that integrates three established theoretical lenses — the **Affective Instance Model (AIM)**, the **Resource-Based View (RBV)**, and the **Technology Acceptance Model (TAM)** — to connect neural biomarkers to discrete stages of the consumer journey. The integration is genuinely novel: no prior work in the A-Tech neuromarketing skill set (see Cross-References below) has combined AIM, RBV, and TAM in a single personalization architecture.

---

## Methodology — PRISMA Systematic Review

| Parameter | Detail |
|-----------|--------|
| Reporting guideline | PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) |
| Databases | Scopus + Web of Science |
| Publication window | 2018–2025 |
| Initial retrieved pool | (full PRISMA flow figure in source; screened for neuromarketing + digital personalization intersection) |
| Final included studies | 30 high-quality studies after inclusion/exclusion, deduplication, and quality appraisal |
| Language | English-language peer-reviewed articles |
| Inclusion criteria | Empirical studies linking neural/physiological measures to digital personalization, consumer-journey stages, or technology acceptance; sufficient methodological detail to extract biomarker-to-stage mappings |
| Exclusion criteria | Editorials, conference abstracts, studies without neural or physiological measurement, pure self-report studies, non-digital contexts |
| Quality appraisal | Standardized risk-of-bias assessment; only studies meeting the high-quality threshold retained |
| Analytical synthesis | Thematic + framework synthesis; three theoretical lenses (AIM, RBV, TAM) applied as deductive coding frames |

### PRISMA Flow Summary

```
Identification   → Scopus + Web of Science records (2018–2025)
Screening        → Title/abstract/keyword filter for neuromarketing × digital personalization
Eligibility      → Full-text review + quality appraisal
Included         → 30 high-quality studies
```

---

## The Three Theoretical Frameworks — Integration

The framework's novelty is the synthesis of three lenses that have historically lived in separate disciplines (affective neuroscience, strategic management, and information systems). Each lens explains a different link in the biomarker-to-behavior chain.

### 1. Affective Instance Model (AIM)

| Attribute | Detail |
|-----------|--------|
| Discipline | Affective neuroscience / consumer psychology |
| Core claim | Emotion is not a background variable but a discrete *instance* — a constructed affective episode shaped by the brain's salience network, interoception, and the current goal context. Each affective instance is brain-state-specific, not a fixed category. |
| Role in framework | Maps neural biomarkers (EEG valence/arousal, autonomic signals) to *affective instances* at each consumer-journey stage. Provides the construct for translating raw neural signal into a personalization-relevant emotional state. |
| Neuromarketing link | EEG frontal alpha asymmetry (approach/withdrawal), theta/beta ratios (cognitive engagement), and autonomic markers (HRV, GSR) index the affective instance the consumer is currently constructing toward the stimulus. |
| Distinct from | Russell's VA and Mehrabian's VAD (captured in `ai-neuromarketing-synergy-framework`). AIM treats each emotional episode as a constructed instance, not a coordinate on a fixed dimensional space. This is the construct the framework uses to *name* what the biomarker detects. |

### 2. Resource-Based View (RBV)

| Attribute | Detail |
|-----------|--------|
| Discipline | Strategic management |
| Core claim | Sustained competitive advantage comes from resources that are Valuable, Rare, Inimitable, and Organized (VRIO). |
| Role in framework | Treats the neuromarketing capability stack — neural data assets, ML model infrastructure, personalization talent, ethical-governance processes — as strategic resources. RBV explains *why* a firm that builds biomarker-driven personalization as a coherent, organized capability gains an advantage that competitors cannot easily copy. |
| Neuromarketing link | Firms with proprietary EEG/eye-tracking corpora, fine-tuned prediction models, and consent-governed data pipelines hold VRIO resources; firms buying off-the-shelf panels do not. |
| Contribution | Positions neuromarketing not as a tactic but as a *capability* whose value depends on organization and ethical governance, not just data volume. |

### 3. Technology Acceptance Model (TAM)

| Attribute | Detail |
|-----------|--------|
| Discipline | Information systems |
| Core claim | Adoption of a technology is driven by Perceived Usefulness (PU) and Perceived Ease of Use (PEOU). Extended TAM adds perceived risk, trust, and social influence. |
| Role in framework | TAM operates on the *consumer side*: even when neural biomarkers predict an affective instance and the firm has the RBV resource to personalize, personalization only changes behavior if the consumer *accepts* the personalized experience. PU/PEOU/perceived-privacy-risk determine whether the consumer engages with, ignores, or rejects the personalized content. |
| Neuromarketing link | TAM explains the last-mile gap: a perfect neural prediction is useless if the consumer perceives the personalization as creepy, inaccurate, or privacy-invasive. |
| Contribution | Adds the acceptance filter that purely neuroscience-driven frameworks omit. Without TAM, the biomarker→behavior link has a hidden moderator: the user's acceptance of the personalization itself. |

### How the Three Lenses Combine

```
   Neural biomarker ──(AIM)──▶ Affective instance ──(RBV)──▶ Personalization capability ──(TAM)──▶ Consumer behavior
   (EEG, autonomic)        (constructed emotion)        (VRIO resource stack)            (acceptance filter)
         │                        │                            │                              │
   What the brain             What it means             Whether the firm can          Whether the consumer
   is doing right now         for the consumer          act on it ethically           will accept the act
```

The framework's causal chain: biomarker → (AIM) → affective instance → (RBV) → firm's organized personalization capability → (TAM) → consumer acceptance → behavior change. Break any link and the system fails: a biomarker without AIM interpretation is noise; an affective instance without RBV-organized capability is insight with no execution; an accepted-but-unwanted personalization with low TAM acceptance is a prediction the consumer rejects.

---

## The 30 Studies — Synthesis by Theme

The 30 included studies (Scopus + Web of Science, 2018–2025) cluster into six thematic groups. Full bibliographic detail is in the source; below is the thematic synthesis the framework draws on.

### Theme 1 — EEG for Scalable Emotional Engagement (dominant signal)
- EEG is the most frequently used biomarker across the 30 studies, chosen for its temporal resolution, declining hardware cost, and compatibility with ML pipelines.
- Frontal alpha asymmetry indexes approach/withdrawal motivation; theta/beta ratio indexes cognitive engagement; frontal midline theta indexes emotional regulation.
- EEG's scalability advantage over fMRI (cost, portability, consumer-grade headsets) makes it the default biomarker for digital personalization at scale.
- Cross-reference: `hybrid-eeg-gaze-decoding-scheme` (EEG + eye-tracking fusion) and `ai-neuromarketing-synergy-framework` (EEG + DL pairing).

### Theme 2 — Machine Learning Enhances Prediction Accuracy to 70–85%
- ML models (SVM, random forest, gradient boosting, shallow CNNs) applied to EEG/autonomic features raise prediction accuracy for consumer preference, purchase intent, and ad-liking into the 70–85% band.
- DL (deep CNNs, RNNs, transformers on EEG) pushes select tasks above 85%, but the review emphasizes the 70–85% band as the *practically reliable* range across the 30 studies — high enough to guide personalization, low enough to demand human oversight.
- Prediction targets: willingness-to-pay, brand preference, ad-liking, purchase intent, content engagement duration.
- Accuracy improves with multimodal fusion (EEG + eye-tracking + autonomic) but degrades in cross-cultural and emerging-market samples where training data is sparse.
- Cross-reference: `predictive-neuromarketing-bayesian-framework` (uncertainty quantification around these accuracies) and `neuromarketing-predictive-purchase-intent-model` (single-variable predictor hierarchy).

### Theme 3 — Consumer-Journey Stage Mapping
- Studies map biomarkers to pre-purchase (attention, preference formation), purchase (decision conflict, choice), and post-purchase (satisfaction, loyalty) stages.
- Pre-purchase dominates the evidence base; purchase and post-purchase biomarker research remains thin — consistent with the gap identified in `neuromarketing-consumer-journey-3x3-framework`.
- The framework uses AIM to give each stage its affective instance label (e.g., curiosity at pre-purchase, decision tension at purchase, relief/satisfaction at post-purchase).

### Theme 4 — Technology Acceptance and Privacy Risk
- Extended-TAM studies in the sample add perceived privacy risk and trust as acceptance moderators for personalized, data-driven experiences.
- Consumers accept personalization when PU and PEOU are high and perceived privacy risk is low; neural-data-based personalization triggers elevated perceived risk, making TAM a binding constraint.
- Cross-reference: `neuro-marketing-privacy-first-behavioral-analytics` and `neuro-personalization-privacy`.

### Theme 5 — Emerging-Market and Cultural Adaptation
- Several studies flag that models trained on WEIRD (Western, Educated, Industrialized, Rich, Democratic) samples underperform in emerging markets due to differences in emotional expression norms, collectivist vs. individualist framing, and physiological baseline variation.
- The review identifies emerging-market adaptation as a persistent, unresolved gap (see Gaps below).

### Theme 6 — Ethics and Governance
- Informed consent for neural data, algorithmic transparency (XAI), manipulation risk, and vulnerable-population protection recur across the sample.
- The review finds ethical governance is *asserted* more often than *operationalized*: most studies name ethics as a limitation but few implement governance mechanisms.
- Cross-reference: `dark-psychology-neuromarketing-autonomy-defense`.

---

## Prediction Accuracy Findings — Detail

| Prediction target | Modal accuracy range | Best-performing model class | Notes |
|-------------------|----------------------|------------------------------|-------|
| Brand preference | 72–84% | SVM / gradient boosting on EEG features | Robust across studies; degrades with cross-cultural transfer |
| Purchase intent | 70–82% | CNN on multimodal EEG + autonomic | Improves with eye-tracking fusion |
| Ad-liking | 74–85% | DL on EEG temporal features | Temporal dynamics matter (see `neural-ad-liking-temporal-dynamics`) |
| Willingness-to-pay | 70–78% | DL (DeePay-style) on EEG | Smaller evidence base; highest variance |
| Content engagement duration | 75–83% | RNN on EEG + behavioral time-series | Strongest in digital/streaming contexts |

**Practical interpretation:** the 70–85% band is the review's headline finding on ML impact. Below 70% the personalization is barely better than a well-targeted heuristic; above 85% the studies are typically single-lab, single-population, and do not survive cross-cultural validation. The 70–85% band is where personalization is *reliable enough to deploy with human oversight but not autonomous*. RBV explains why the firm that holds the proprietary training corpus to push its own context past 85% gains a rare, inimitable resource.

---

## Theoretical Contributions

The framework extends two established theories:

### Dual-Process Theory Extension
- Dual-process theory (System 1 fast/automatic, System 2 slow/deliberative) is extended by the framework's AIM layer: affective instances are not purely System 1. AIM's constructionist view shows that even "fast" emotional responses recruit goal-context and interoceptive inputs that look more System-2-like than the classic fast/slow split allows.
- Contribution: neuromarketing biomarkers do not index a clean System-1 vs. System-2 divide; they index *constructed affective instances* that blend both systems. This reframes how practitioners should interpret an EEG signal — not as a raw instinct but as a context-constructed state.

### Prospect Theory Extension
- Prospect theory (loss aversion, reference-dependence) is extended by linking neural biomarkers to the reference-point formation process: the affective instance at the pre-purchase stage *sets* the reference point against which purchase-stage gains/losses are evaluated.
- Contribution: biomarkers measured pre-exposure help predict the shape of the loss-aversion curve at the purchase stage, making prospect-theory parameters individually estimable rather than population-averaged.

---

## Managerial Implications

| Implication | What managers should do | Framework lens |
|-------------|-------------------------|----------------|
| Build the biomarker pipeline as a VRIO resource | Invest in proprietary, consent-governed EEG/autonomic corpora and fine-tuned ML models; off-the-shelf panels are not rare or inimitable | RBV |
| Personalize at the affective-instance level, not the demographic level | Use AIM to label the consumer's current constructed emotional state and personalize to that instance, not to a segment average | AIM |
| Treat acceptance as the binding constraint | Design personalization for high PU/PEOU and low perceived privacy risk; the best neural prediction is worthless if the consumer rejects it | TAM |
| Apply human oversight in the 70–85% band | ML predictions in this band are deployment-grade *with* review, not autonomous; build review checkpoints | All three |
| Localize for emerging markets | Do not transfer WEIRD-trained models without re-validation; cultural adaptation is a capability, not a tweak | RBV + AIM |
| Operationalize ethics, don't just assert it | Implement consent architecture, XAI, manipulation-risk review, and vulnerable-population protection as process resources | RBV + TAM |

---

## Persistent Gaps (from the review)

### Gap 1 — Emerging-Market Adaptation
- Models trained on Western samples underperform in emerging markets; emotional expression norms, collectivist framing, and physiological baselines differ.
- Few studies in the 30-study set originate in or validate on emerging-market populations.
- Implication: the 70–85% accuracy headline is a WEIRD-sample accuracy headline; cross-cultural transfer accuracy is lower and under-reported.

### Gap 2 — ROI Demonstration
- The review finds that neuromarketing personalization is rarely tied to clean ROI measurement. Most studies measure prediction accuracy, not incremental revenue, retention, or LTV.
- RBV's VRIO test requires the resource to be *valuable* in financial terms; the evidence base largely does not close that loop.
- Implication: practitioners must build the biomarker→behavior→revenue measurement chain themselves; the academic evidence stops at prediction accuracy.

### Gap 3 — Ethical Governance Operationalization
- Ethics is asserted in most studies but operationalized in few. Consent architecture, XAI, manipulation-risk review, and vulnerable-population protections are named as limitations, not implemented as methods.
- TAM's perceived-risk dimension makes this gap commercially material: poor governance raises perceived risk, which lowers acceptance, which breaks the final link in the framework's causal chain.

---

## Limitations of the Review

- **Sample size:** 30 studies is a high-quality but small evidence base; the 70–85% accuracy band is drawn from a limited set and may shift as more studies publish.
- **Database scope:** Scopus + Web of Science may exclude relevant work in discipline-specific databases (PubMed for clinical-adjacent work, ACM for HCI).
- **Publication window:** 2018–2025 captures the ML-acceleration era but misses earlier foundational biomarker work.
- **WEIRD dominance:** the evidence base is skewed toward Western samples, compounding the emerging-market adaptation gap.
- **Framework status:** the Neuromarketing-Digital Personalization Framework is *conceptual* — proposed from synthesis, not yet empirically tested as an integrated whole. The AIM+RBV+TAM integration is a theoretical contribution awaiting validation.
- **ROI evidence:** as the review itself notes, the link from prediction accuracy to business ROI is the weakest evidentiary link.

---

## Cross-References to Existing A-Tech Neuromarketing Skills

This framework is **new** in its AIM+RBV+TAM integration. It complements — and should be used alongside — the following existing skills:

| Existing skill | Relationship | When to use that skill instead |
|----------------|--------------|--------------------------------|
| `ai-neuromarketing-synergy-framework` | Shares the EEG/ML emphasis and emotion-attention-memory triad; that skill covers the AI-neuro *pairing* taxonomy, this skill covers the *personalization architecture* built on top of it | Selecting which AI model pairs with which neural signal |
| `neuromarketing-consumer-journey-3x3-framework` | Shares the consumer-journey stage mapping; that skill provides the 3×3 affective/behavioral/cognitive typology, this skill adds the AIM affective-instance layer and the RBV/TAM acceptance filter | Designing a stage-by-stage measurement plan |
| `neuromarketing-2026-practical-operating-model` | That skill is the practical campaign-execution layer (six-layer operating model, 90-day roadmap); this skill is the *strategic-capability* layer above it | Executing a campaign |
| `predictive-neuromarketing-bayesian-framework` | That skill quantifies uncertainty around predictions; the 70–85% accuracy band here is exactly where Bayesian calibration adds most value | Quantifying prediction uncertainty |
| `neuromarketing-predictive-purchase-intent-model` | That skill provides the single-variable predictor hierarchy; this skill provides the strategic wrapper around it | Building a purchase-intent predictor |
| `hybrid-eeg-gaze-decoding-scheme` | That skill implements the EEG + eye-tracking fusion the 70–85% band improves with | Implementing multimodal decoding |
| `neuro-marketing-privacy-first-behavioral-analytics` | That skill provides the privacy architecture TAM's perceived-risk dimension requires | Building privacy-first proxies |
| `neuro-personalization-privacy` | That skill covers the personalization-privacy tension directly | Privacy-preserving personalization design |
| `dark-psychology-neuromarketing-autonomy-defense` | That skill provides the autonomy-defense guardrails the ethical-governance gap requires | Defending against manipulation |
| `neuromarketing-research-landscape-2026` | That skill maps the bibliometric landscape; this skill is a within-landscape deep dive on the personalization sub-domain | Surveying the whole field |
| `neuromarketing-lda-five-pillar-taxonomy` | That skill provides the LDA topic-model taxonomy; this skill's themes overlap but add the theoretical-lens integration | Topic-level field mapping |
| `neural-ad-liking-temporal-dynamics` | That skill covers the temporal-dynamics detail behind the 74–85% ad-liking accuracy | Temporal ad-liking modeling |
| `customer-digital-twin-neuromarketing` | That skill covers the digital-twin construct; this framework's affective-instance layer is the signal that feeds a twin | Building a consumer digital twin |
| `dynamic-ai-personalization-nexus` | That skill covers the dynamic personalization nexus; this framework supplies the theoretical grounding (AIM/RBV/TAM) for it | Dynamic personalization architecture |

---

## Source

- Mandal, A., & Tabib, P.A. (2026). Conceptual Neuromarketing-Digital Personalization Framework. *Advances in Consumer Research*, 2026. PRISMA-guided systematic review; 30 studies from Scopus and Web of Science (2018–2025); AIM + RBV + TAM integration.